Mentice
Private Company
Funding information not available
Overview
Mentice is a global leader in simulation-based training and procedural planning for image-guided interventional therapies, serving both healthcare systems and the medical device industry. The company's core value proposition lies in its ability to replicate complex vascular anatomy and hemodynamics, providing a realistic environment for clinicians to master procedures and for medtech firms to accelerate product development and adoption. With a claimed trust from 10 out of 10 of the world's leading health systems and leading medtech companies, Mentice has established itself as a key partner in advancing procedural safety and efficiency. Its business model leverages a combination of software, hardware, and customized services to address the growing need for standardized, competency-based training in high-stakes medical fields like cardiology, neurovascular, and peripheral vascular interventions.
Technology Platform
Integrated suite of virtual reality simulators, physiological flow models, and software for realistic simulation of image-guided interventional procedures. Platform supports real patient anatomy import, cloud/mobile applications, and tools for medical device development and training.
Opportunities
Risk Factors
Competitive Landscape
Mentice operates in a competitive medical simulation market with rivals such as Surgical Science (formerly 3D Systems), CAE Healthcare, and Simbionix (acquired by 3D Systems, now part of Surgical Science). Its key differentiator is its deep focus on physiological fidelity (Flow models) and its strong dual-channel strategy serving both hospitals and medical device companies directly. Competition is based on technological realism, breadth of procedure library, integration capabilities, and clinical validation.